Literature DB >> 11934720

Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy.

Virginia A Imadojemu1, Kevin Gleeson, Sadeq A Quraishi, Allen R Kunselman, Lawrence I Sinoway, Urs A Leuenberger.   

Abstract

Obstructive sleep apnea causes cardiovascular morbidity and premature death. Potential links between sleep apnea and cardiovascular complications are chronically elevated activity of the sympathetic nervous system and abnormal vascular function. To explore vascular function, we determined the reactive hyperemic blood flow (RHBF) responses to 10 minutes of forearm arterial occlusion (plethysmography), blood pressure, and muscle sympathetic nerve activity (MSNA, microneurography) in eight patients with sleep apnea and in nine nonapneic control subjects. Peak RHBF and vascular conductance were markedly attenuated in sleep apnea compared with control subjects (p < 0.05). Seven sleep apnea patients were retested after at least two weeks of continuous positive airway pressure (CPAP) therapy. MSNA decreased after CPAP therapy (p < 0.05, n = 6), whereas blood pressure did not change. After CPAP therapy, peak RHBF and vascular conductance were increased compared with before treatment (p < 0.05; n = 7). Thus, vascular function is abnormal in sleep apnea and is improved by CPAP therapy. Furthermore, effective CPAP therapy decreases sympathetic activity in sleep apnea. Thus, sympathoexcitation and abnormal vascular function in patients with sleep apnea appear to be linked to the repetitive nocturnal apneic events.

Entities:  

Keywords:  Non-programmatic

Mesh:

Year:  2002        PMID: 11934720     DOI: 10.1164/ajrccm.165.7.2102003

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  28 in total

1.  Effect of AT1 receptor blockade on intermittent hypoxia-induced endothelial dysfunction.

Authors:  Noah J Marcus; Nathan R Philippi; Cynthia E Bird; Yu-Long Li; Harold D Schultz; Barbara J Morgan
Journal:  Respir Physiol Neurobiol       Date:  2012-06-21       Impact factor: 1.931

2.  Long-term effects of nasal continuous positive airway pressure on vasodilatory endothelial function in obstructive sleep apnea syndrome.

Authors:  Hans-W Duchna; Maritta Orth; Gerhard Schultze-Werninghaus; Christian Guilleminault; Riccardo A Stoohs
Journal:  Sleep Breath       Date:  2005-09       Impact factor: 2.816

3.  Impaired coronary flow reserve in obstructive sleep apnea and its improvement after continuous positive airway pressure therapy: a transthoracic Doppler echocardiographic study.

Authors:  Kikuko Obase; Hiroyuki Okura; Keiji Mouri; Tomoko Maehama; Akihiro Hayashida; Nozomi Watanabe; Yoji Neishi; Takahiro Kawamoto; Mikio Oka; Kiyoshi Yoshida
Journal:  J Echocardiogr       Date:  2010-12-08

4.  Blood Pressure Increases in OSA due to Maintained Neurovascular Sympathetic Transduction: Impact of CPAP.

Authors:  Renaud Tamisier; Can Ozan Tan; Jean-Louis Pepin; Patrick Levy; J Andrew Taylor
Journal:  Sleep       Date:  2015-12-01       Impact factor: 5.849

5.  The effect of one night of continuous positive airway pressure therapy on oxidative stress and antioxidant defense in hypertensive patients with severe obstructive sleep apnea.

Authors:  Mohammed A Alzoghaibi; Ahmed S Bahammam
Journal:  Sleep Breath       Date:  2011-05-13       Impact factor: 2.816

6.  Association of sleep-disordered breathing and the occurrence of stroke.

Authors:  Michael Arzt; Terry Young; Laurel Finn; James B Skatrud; T Douglas Bradley
Journal:  Am J Respir Crit Care Med       Date:  2005-09-01       Impact factor: 21.405

7.  Treatment of obstructive sleep apnoea leads to improved microvascular endothelial function in the systemic circulation.

Authors:  J L Lattimore; I Wilcox; M Skilton; M Langenfeld; D S Celermajer
Journal:  Thorax       Date:  2006-03-14       Impact factor: 9.139

8.  Nasal continuous positive airway pressure improves myocardial perfusion reserve and endothelial-dependent vasodilation in patients with obstructive sleep apnea.

Authors:  Patricia K Nguyen; Chandra K Katikireddy; Michael V McConnell; Clete Kushida; Phillip C Yang
Journal:  J Cardiovasc Magn Reson       Date:  2010-09-03       Impact factor: 5.364

Review 9.  Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome.

Authors:  Luciano F Drager; Sônia M Togeiro; Vsevolod Y Polotsky; Geraldo Lorenzi-Filho
Journal:  J Am Coll Cardiol       Date:  2013-06-12       Impact factor: 24.094

Review 10.  Obstructive sleep apnea, immuno-inflammation, and atherosclerosis.

Authors:  Claire Arnaud; Maurice Dematteis; Jean-Louis Pepin; Jean-Philippe Baguet; Patrick Lévy
Journal:  Semin Immunopathol       Date:  2009-04-29       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.